Biomimetic Self‐Propelled Asymmetric Nanomotors for Cascade‐Targeted Treatment of Neurological Inflammation
Advanced Science · 2024
DOI: 10.1002/advs.202310211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Jiamin Ye und 10 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin, 300072, China. Hauptthemen laut MEDLINE: Silicon Dioxide, Biomimetics, Blood-Brain Barrier. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Technology & Innovation Commission of Shenzhen Municipality, National Outstanding Youth Science Fund Project of National Natural Science Foundation of China.
Abstract (Originalsprache)
The precise targeted delivery of therapeutic agents to deep regions of the brain is crucial for the effective treatment of various neurological diseases. However, achieving this goal is challenging due to the presence of the blood‒brain barrier (BBB) and the complex anatomy of the brain. Here, a biomimetic self‐propelled nanomotor with cascade targeting capacity is developed for the treatment of neurological inflammatory diseases. The self‐propelled nanomotors are designed with biomimetic asymmetric structures with a mesoporous SiO 2 head and multiple MnO 2 tentacles. Macrophage membrane biomimetic modification endows nanomotors with inflammatory targeting and BBB penetration abilities The MnO 2 agents catalyze the degradation of H 2 O 2 into O 2 , not only by reducing brain inflammation but also by providing the driving force for deep brain penetration. Additionally, the mesoporous SiO 2 head is loaded with curcumin, which actively regulates macrophage polarization from the M1 to the M2 phenotype. All in vitro cell, organoid model, and in vivo animal experiments confirmed the effectiveness of the biomimetic self‐propelled nanomotors in precise targeting, deep brain penetration, anti‐inflammatory, and nervous system function maintenance. Therefore, this study introduces a platform of biomimetic self‐propelled nanomotors with inflammation targeting ability and active deep penetration for the treatment of neurological inflammation diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Academy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin, 300072, China.
- Department of General Surgery, the First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, 100853, China.
- Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 100730, China.
- Medical College, Linyi University, Linyi, 276000, China.
ORCID-Profile: Xiaoyuan Ji
Förderung
- National Natural Science Foundation of China
- Technology & Innovation Commission of Shenzhen Municipality
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
Zitieren
APA
Ye, J., Fan, Y., She, Y., Shi, J., Yang, Y., Yuan, X., Li, R., Han, J., Liu, L., Kang, Y., & Ji, X. (2024). Biomimetic Self‐Propelled Asymmetric Nanomotors for Cascade‐Targeted Treatment of Neurological Inflammation. Advanced Science. https://doi.org/10.1002/advs.202310211
Vancouver
Ye J, Fan Y, She Y, Shi J, Yang Y, Yuan X, et al. Biomimetic Self‐Propelled Asymmetric Nanomotors for Cascade‐Targeted Treatment of Neurological Inflammation. Advanced Science. 2024. doi:10.1002/advs.202310211
BibTeX
@article{Ye2024,
author = {Ye, Jiamin and Fan, Yueyue and She, Yaoguang and Shi, Jiacheng and Yang, Yiwen and Yuan, Xue and Li, Ruiyan and Han, Jingwen and Liu, Luntao and Kang, Yong and Ji, Xiaoyuan},
title = {Biomimetic Self‐Propelled Asymmetric Nanomotors for Cascade‐Targeted Treatment of Neurological Inflammation},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202310211}
}
EUVIMED